Table 2 Socio-demographic characteristics of the study participants
Variable | Total (n) | Cases (%) | Controls (%) | |
|---|---|---|---|---|
Age (years) | 40 – 50 | 85 | 29 (29%) | 56 (28%) |
50 – 60 | 92 | 31 (31%) | 61 (30.5%) | |
60 – 70 | 89 | 31 (31%) | 58 (29%) | |
70 – 80 | 30 | 8 (8%) | 22 (11%) | |
> 80 | 4 | 1 (1%) | 3 (1.5%) | |
Duration of diabetes since diagnosis | < 5 years | 23 | 23 (23 %) | - |
5 - 10 years | 30 | 30 (30 %) | - | |
>10 years | 47 | 47 (47 %) | - | |
Sex | Female | 168 | 56 (56%) | 112 (56%) |
Male | 132 | 44 (44%) | 88 (44%) | |
Complications arising from diabetes | Retinopathy | 8 | 8 (8%) | - |
Nephropathy | 33 | 33 (33%) | - | |
Neuropathy | 27 | 27 (27%) | - | |
Peripheral arterial disease | 3 | 3 (3%) | - | |
Stroke/TIA | 2 | 2 (2%) | - | |
Laboratory results | LDL (mg/dl) | 105.9 ± 39.7 | 105.9 ± 39.7 | - |
HbA1C (%) | 8.7 ± 1.6 | 8.7± 1.6 | - | |
Triglyceride (mg/dl) | 155.5 ± 87.1 | 155.5 ± 87.1 | - | |
Comorbidity | Dyslipidemia | 46 | 26 (26%) | 20 (10%) |
Hypertension | 47 | 47 (47%) | - | |
CKD | 9 | 9 (9%) | - | |
HIV | 7 | 7 (7%) | 8 (4%) | |
Cholelithiasis | 40 | - | 40 (20%) | |
BPH | 50 | - | 50 (25%) | |
Nephrolithiasis | 17 | - | 17 (8%) | |
Malignancy | 30 | - | 30 (15%) | |
COPD | 20 | - | 20 (10%) | |
Hip Fracture | 20 | - | 20 (10%) | |
Thyroid Nodule | 10 | - | 10 (5%) | |